通过多omics分析和机器学习识别甲状腺癌的潜在分子标
Bo Zhang1, Xue-Yong Zheng1, Xiao-Hua Tai1
1Department of Thyroid Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Annals of medicine and surgery (2012)
|December 11, 2025
概括
研究人员确定FN1和CRABP1是甲状腺癌的关键分子标记物. 这些基因影响瘤生长和免疫反应,为早期诊断和量身定制的治疗提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 在全球范围内,甲状腺癌的发病率正在上升.
- 新型分子标记物对于早期检测和个性化治疗至关重要.
研究的目的:
- 为了确定甲状腺癌的新型分子标记物.
- 研究已识别的基因在瘤进展和免疫反应中的作用.
主要方法:
- 甲状腺癌微阵列数据的差异基因表达分析.
- 机器学习和权重基因共同表达网络分析 (WGCNA) 用于签名基因识别.
- 使用免疫组织化学和RT-PCR验证.
主要成果:
- 确定了348个差异表达基因 (DEGs),其中18个被选为特征基因.
- WGCNA突出显示了12个关键基因;FN1和CRABP1显示了与临床特征,生存和免疫透的显著联系.
- 在甲状腺癌组织中,CRABP1被下调,FN1被上调.
结论:
- FN1和CRABP1是甲状腺癌的潜在分子标.
- 这些基因影响瘤的进展,免疫反应和预后.
- 研究结果为早期诊断和个性化治疗策略提供了洞察力.
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:02Genomics
39.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.5K